Rocket Lab's stock fell 8% after reporting a mixed Q2 with strong revenue growth of 62% to $234 million and a record backlog of $2.36 billion, but a wider-than-expected adjusted loss of $0.08 per share. Investor concerns center on the delayed timeline for the Neutron rocket, a key growth driver, now possibly pushing its launch beyond 2026. The company also forecasted a larger adjusted EBITDA loss for Q3 than analysts expected, overshadowing its contract wins including a $266 million U.S. Space Force deal. The next major catalyst for the stock depends on progress with Neutron's development and testing, as investors weigh growth against execution risks.
Tractor Supply's CEO, Lawton, purchased 15,600 shares of the company for $501,540 despite the stock having declined 44%. This insider buying signals confidence in the company's future prospects even as the stock price has fallen significantly. Such m...
AtlasClear Holdings has launched a redesigned corporate website that consolidates its operating businesses, technology roadmap, and investor resources in one place. The new site highlights its current clearing and brokerage services through subsidiar...
Advanced Micro Devices (AMD) reported strong Q2 2026 results with revenue rising 1.5 times year-over-year to $11.5 billion, driven by a doubling of data center sales to $6.7 billion. Despite this rapid growth, AMD's $789 billion valuation already ref...
Chipotle Mexican Grill's stock fell 12.64% recently, reflecting concerns after its Q2 report showed slim revenue beats but declining restaurant-level margins and rising costs. Management warned of consumer caution and sales headwinds, projecting only...
BioHarvest Sciences reported a 3.8% revenue increase to $8.8 million in Q2 and narrowed its net loss to $3.7 million. The company shifted focus to manufacturing capacity and secured a deal to produce 20 tons of a rare, high-value fragrance ingredient...
